Veracyte, Inc.
DE ˙ DB ˙ US92337F1075
37,64 € ↑0,08 (0,21%)
2026-05-28
AKTIENPREIS
SecurityDE:12V / Veracyte, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership102,643 shares
Latest Disclosed Value $ 4,321,270
Alliancebernstein L.p. reports 0.46% increase in ownership of 12V / Veracyte, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 102,643 shares of Veracyte, Inc. (DE:12V) valued at $2,730,304 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 102,172 shares of Veracyte, Inc.. This represents a change in shares of 0.46% during the quarter. The current value of the position is $3,863,483 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VERACYTE COM 92337F107 102,643 471 0.46 4,321 0.47 0.0014
2026-02-17 2025-12-31 13F VERACYTE COM 92337F107 102,172 8,332 8.88 4,301 33.53 0.0014
2025-11-14 2025-09-30 13F VERACYTE COM 92337F107 93,840 -347 -0.37 3,222 26.56 0.0010
2025-08-14 2025-06-30 13F VERACYTE COM 92337F107 94,187 2,167 2.35 2,546 -6.71 0.0008
2025-05-15 2025-03-31 13F VERACYTE COM 92337F107 92,020 -6,400 -6.50 2,728 -30.00 0.0010
2025-02-12 2024-12-31 13F VERACYTE COM 92337F107 98,420 2,000 2.07 3,897 18.74 0.0013
2024-11-14 2024-09-30 13F VERACYTE COM 92337F107 96,420 -3,000 -3.02 3,282 52.37 0.0011
2024-08-14 2024-06-30 13F VERACYTE COM 92337F107 99,420 0 0.00 2,154 -2.22 0.0008
2024-05-14 2024-03-31 13F VERACYTE COM 92337F107 99,420 -1,970 -1.94 2,203 -21.01 0.0008
2024-02-14 2023-12-31 13F VERACYTE COM 92337F107 101,390 2,300 2.32 2,789 26.08 0.0011
2023-11-14 2023-09-30 13F VERACYTE COM 92337F107 99,090 -1,241 -1.24 2,213 -13.42 0.0009
2023-08-15 2023-06-30 13F VERACYTE COM 92337F107 100,331 22,431 28.79 2,555 47.09 0.0010
2023-05-15 2023-03-31 13F VERACYTE COM 92337F107 77,900 0 0.00 1,737 -6.01 0.0007
2023-02-15 2022-12-31 13F VERACYTE COM 92337F107 77,900 0 0.00 1,849 42.92 0.0008
2022-11-15 2022-09-30 13F VERACYTE COM 92337F107 77,900 0 0.00 1,293 -16.58 0.0006
2022-08-15 2022-06-30 13F VERACYTE COM 92337F107 77,900 0 0.00 1,550 -27.84 0.0007
2022-05-13 2022-03-31 13F VERACYTE COM 92337F107 77,900 -35,120 -31.07 2,148 -53.87 0.0008
2022-02-14 2021-12-31 13F VERACYTE COM 92337F107 113,020 34,630 44.18 4,656 27.88 0.0016
2021-11-10 2021-09-30 13F VERACYTE COM 92337F107 78,390 90 0.11 3,641 16.33 0.0014
2021-07-30 2021-06-30 13F VERACYTE COM 92337F107 78,300 0 0.00 3,130 -25.64 0.0013
2021-05-06 2021-03-31 13F VERACYTE COM 92337F107 78,300 700 0.90 4,209 10.82 0.0018
2021-02-08 2020-12-31 13F VERACYTE COM 92337F107 77,600 600 0.78 3,798 51.80 0.0018
2020-11-12 2020-09-30 13F VERACYTE COM 92337F107 77,000 13,200 20.69 2,502 51.45 0.0013
2020-08-13 2020-06-30 13F VERACYTE COM 92337F107 63,800 0 0.00 1,652 6.51 0.0010
2020-05-14 2020-03-31 13F VERACYTE COM 92337F107 63,800 -1,000 -1.54 1,551 -14.26 0.0011
2020-02-18 2019-12-31 13F VERACYTE COM 92337F107 64,800 1,000 1.57 1,809 18.16 0.0010
2019-11-14 2019-09-30 13F VERACYTE COM 92337F107 63,800 1,500 2.41 1,531 -13.80 0.0010
2019-08-14 2019-06-30 13F VERACYTE COM 92337F107 62,300 31,900 104.93 1,776 133.38 0.0011
2019-05-14 2019-03-31 13F VERACYTE COM 92337F107 30,400 2,000 7.04 761 113.17 0.0005
2019-02-13 2018-12-31 13F VERACYTE COM 92337F107 28,400 15,100 113.53 357 181.10 0.0003
2018-11-08 2018-09-30 13F VERACYTE COM 92337F107 13,300 2,700 25.47 127 28.28 0.0001
2018-08-13 2018-06-30 13F VERACYTE COM 92337F107 10,600 10,600 99 0.0001
2015-08-14 2015-06-30 13F VERACYTE COM 92337F107 0 -500 -100.00 0 -100.00
2015-05-13 2015-03-31 13F VERACYTE COM 92337F107 500 0 0.00 4 -20.00 0.0000
2015-02-13 2014-12-31 13F VERACYTE COM 92337F107 500 0 0.00 5 0.00 0.0000
2014-11-13 2014-09-30 13F VERACYTE COM 92337F107 500 -500 -50.00 5 -70.59 0.0000
2014-08-13 2014-06-30 13F VERACYTE COM 92337F107 1,000 1,000 17 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.